GLP-1 receptor agonists’ impact on cardio-renal outcomes and mortality in T2D with acute kidney disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
GLP-1 receptor agonists’ impact on cardio-renal outcomes and mortality in T2D with acute kidney disease ; volume:15 ; number:1 ; day:13 ; month:7 ; year:2024 ; pages:1-10 ; date:12.2024
Nature Communications ; 15, Heft 1 (13.7.2024), 1-10, 12.2024
- Urheber
-
Pan, Heng-Chih
Chen, Jui-Yi
Chen, Hsing-Yu
Yeh, Fang-Yu
Sun, Chiao-Yin
Huang, Thomas Tao-Min
Wu, Vin-Cent
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-50199-y
- URN
-
urn:nbn:de:101:1-2410020932041.365349727745
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pan, Heng-Chih
- Chen, Jui-Yi
- Chen, Hsing-Yu
- Yeh, Fang-Yu
- Sun, Chiao-Yin
- Huang, Thomas Tao-Min
- Wu, Vin-Cent
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT)
Detrimental role of humoral signalling in cardio-renal cross-talk
A multisystem, cardio-renal investigation of post-COVID-19 illness
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle
Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study
Could Repeated Cardio-Renal Injury Trigger Late Cardiovascular Sequelae in Extreme Endurance Athletes?
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all
Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome
Association of cardio-renal biomarkers and mortality in the U.S.: a prospective cohort study
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT)
Detrimental role of humoral signalling in cardio-renal cross-talk
A multisystem, cardio-renal investigation of post-COVID-19 illness
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle
Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study
Could Repeated Cardio-Renal Injury Trigger Late Cardiovascular Sequelae in Extreme Endurance Athletes?
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all
Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome
Association of cardio-renal biomarkers and mortality in the U.S.: a prospective cohort study
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT)
Detrimental role of humoral signalling in cardio-renal cross-talk
A multisystem, cardio-renal investigation of post-COVID-19 illness
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle
Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study
Could Repeated Cardio-Renal Injury Trigger Late Cardiovascular Sequelae in Extreme Endurance Athletes?
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all
Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome
Association of cardio-renal biomarkers and mortality in the U.S.: a prospective cohort study
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes